Skip to main content
. 2020 Feb 18;35(2):593–601. doi: 10.1007/s00464-020-07420-y

Table 2.

Univariate analyses of demographic and clinical characteristics of low- and high-risk patients with clinical N0 pathological T1b esophageal squamous cell carcinoma

Variable Low-risk group (n = 148) High-risk group (n = 19) p valuea
Sex 0.067
 Male 113(76.35) 18(94.74%
 Female 35(23.65) 1(5.26)
Age 63.02 ± 7.3 62.05 ± 8.52 0.946
Surgical approach
 McKeown 135(91.22) 16(84.21) 0.329
 Ivor–Lewis 13(8.78) 3(15.79)
 Minimally invasive esophagectomy 122(82.43) 14(73.68) 0.356
 Open 26(17.57) 5(26.32)
Number of LND 24.48 ± 7.90 23.11 ± 6.60 0.504a
Tumor location in the esophagus 0.904
 Upper third 18(12.16) 3(15.79)
 Middle third 97(65.54) 12(63.16)
 Lower third 33(22.3) 4(21.05)
Differentiation  < 0.001
 Well 70(47.3) 2(10.53)
 Moderate 41(27.7) 5(26.32)
 Poor 37(25) 12(63.16)
Depth of invasion  < 0.001
 sm1 93(62.84) 3(15.79)
 sm2 43(29.05) 5(26.32)
 sm3 12(8.11) 11(57.89)
LVI 10 (6.76) 0 0.243
Tumor length (mm) 17.18 ± 10.53 23.71 ± 6.85  < 0.001a
 < 20 mm 81(54.73) 1(5.26)
 ≥ 20 mm 67(45.27) 18(94.73)

Values are presented as number, number(percent), or mean ± standard deviation

aMann–Whitney U test; LND number of lymph nodes dissected, LVI lymphovascular invasion, sm1 invasion of the upper third of the submucosal layer or reaching the submucosal layer > 200 µm from the muscularis, sm2 invasion reaching the middle third of the submucosal layer, sm3 invasion reaching the lower third of the submucosal layer